138 related articles for article (PubMed ID: 3763367)
1. Specimen handling in an HPLC determination of phenylbutazone and its major metabolites in plasma, avoiding degradation of the compounds.
Franssen MJ; Tan Y; Freij I; Van Ginneken CA; Gribnau FW
Pharm Weekbl Sci; 1986 Aug; 8(4):229-33. PubMed ID: 3763367
[TBL] [Abstract][Full Text] [Related]
2. Solid-phase extraction for the high-performance liquid chromatographic determination of indomethacin, suxibuzone, phenylbutazone and oxyphenbutazone in plasma, avoiding degradation of compounds.
Caturla MC; Cusido E
J Chromatogr; 1992 Oct; 581(1):101-7. PubMed ID: 1429991
[TBL] [Abstract][Full Text] [Related]
3. [Determination of bumadizone, phenylbutazone and oxyphenbutazone in human plasma by high-performance liquid chromatography (author's transl)].
Spahn H; Mutschler E
Arzneimittelforschung; 1981; 31(3):495-9. PubMed ID: 6894379
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of phenylbutazone and its metabolites in plasma and urine by high-performance liquid chromatography.
Marunaka T; Shibata T; Minami Y; Umeno Y
J Chromatogr; 1980 Sep; 183(3):331-8. PubMed ID: 7419650
[TBL] [Abstract][Full Text] [Related]
5. Determination of phenylbutazone and oxyphenbutazone in plasma and urine samples of horses by high-performance liquid chromatography and gas chromatography-mass spectrometry.
Neto LM; Andraus MH; Salvadori MC
J Chromatogr B Biomed Appl; 1996 Apr; 678(2):211-8. PubMed ID: 8738024
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of phenylbutazone and oxyphenbutazone in plasma by high-speed liquid chromatography.
Pound NJ; Sears RW
J Pharm Sci; 1975 Feb; 64(2):284-7. PubMed ID: 1127584
[TBL] [Abstract][Full Text] [Related]
7. Separation of furosemide, phenylbutazone and oxyphenbutazone in plasma by direct injection onto internal surface reversed-phase columns with systematic optimization of selectivity.
Pinkerton TC; Perry JA; Rateike JD
J Chromatogr; 1986 Oct; 367(2):412-8. PubMed ID: 3782354
[No Abstract] [Full Text] [Related]
8. Screening, quantification, and confirmation of phenylbutazone and oxyphenbutazone in equine plasma by liquid chromatography-tandem mass spectrometry.
You Y; Uboh CE; Soma LR; Guan F; Li X; Rudy JA; Chen J
J Anal Toxicol; 2009; 33(1):41-50. PubMed ID: 19161668
[TBL] [Abstract][Full Text] [Related]
9. Quantification of phenylbutazone in equine sera by use of high-performance liquid chromatography with a nonevaporative extraction technique.
Peck KE; Ray AC; Manuel G; Rao MM; Foos J
Am J Vet Res; 1996 Nov; 57(11):1522-4. PubMed ID: 8915422
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of hydrocortisone, dexamethasone, indomethacin, phenylbutazone and oxyphenbutazone in equine serum by high-performance liquid chromatography.
Grippa E; Santini L; Castellano G; Gatto MT; Leone MG; Saso L
J Chromatogr B Biomed Sci Appl; 2000 Jan; 738(1):17-25. PubMed ID: 10778922
[TBL] [Abstract][Full Text] [Related]
11. [Determination of feprazone and one of its metabolites in human plasma after high-performance liquid chromatographic or thin-layer chromatographic separation].
Spahn H; Mutschler E
J Chromatogr; 1982 Oct; 232(1):145-53. PubMed ID: 7142323
[TBL] [Abstract][Full Text] [Related]
12. GLC determination of plasma concentration of phenylbutazone and its metabolite oxyphenbutazone.
Midha KK; McGilveray IJ; Charette C
J Pharm Sci; 1974 Aug; 63(8):1234-9. PubMed ID: 4852201
[No Abstract] [Full Text] [Related]
13. A supercritical fluid chromatographic method using packed columns for phenylbutazone and oxyphenbutazone in serum, and for phenylbutazone in a dosage form.
Simmons BR; Jagota NK; Stewart JT
J Pharm Biomed Anal; 1995 Jan; 13(1):59-64. PubMed ID: 7718635
[TBL] [Abstract][Full Text] [Related]
14. Direct injection HPLC method for the determination of phenylbutazone and oxyphenylbutazone in serum using a semipermeable surface column.
Haque A; Stewart JT
J Pharm Biomed Anal; 1997 Oct; 16(2):287-93. PubMed ID: 9408846
[TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)].
Spahn H; Mutschler E; Geissler HE; Faust-Tinnefeldt G
Arzneimittelforschung; 1981; 31(3):499-503. PubMed ID: 6894380
[TBL] [Abstract][Full Text] [Related]
17. The intramuscular bioavailability of a phenylbutazone preparation in the horse.
Landuyt J; Delbeke FT; Debackere M
J Vet Pharmacol Ther; 1993 Dec; 16(4):494-500. PubMed ID: 8126767
[TBL] [Abstract][Full Text] [Related]
18. [Quantitative determination of feprazone in the presence of possible degradation by HPLC].
Facchini G; Filippi G; Cantoni R; Nannetti M
Boll Chim Farm; 1987 Jun; 126(6):244-5. PubMed ID: 3451746
[No Abstract] [Full Text] [Related]
19. Simultaneous high-performance liquid chromatographic determination of suxibuzone and its metabolites in plasma and urine.
Marunaka T; Shibata T; Minami Y; Umeno Y; Shindo T
J Pharm Sci; 1980 Nov; 69(11):1258-61. PubMed ID: 7452452
[TBL] [Abstract][Full Text] [Related]
20. Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after treatment with various dosage regimens.
Soma LR; Sams R; Duer W; Tobin T; Woodward C; McDonald J
Am J Vet Res; 1985 Apr; 46(4):932-8. PubMed ID: 4014842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
